Psyllium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Condition:   Constipation-predominant IBS (IBS-C)Interventions:   Dietary Supplement: NTX-1;   Drug: psyllium (15 g)Sponsors:   Nutrabiotix, LLC;   Rush University Medical CenterRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2014 Category: Research Source Type: clinical trials